Osteoporosis Affects Functional Activity and Gene Expression of Osteoblastic Cells Derived from Rat Alveolar Bone

Brazilian Dental Journal - Tập 31 Số 6 - Trang 617-622
Paula Katherine Vargas Sánchez1, Roger Rodrigo Fernandes1, Flávia Aparecida Chaves Furlaneto2, Luiz Gustavo de Sousa1, Selma Siéssere1, Karina Fittipaldi Bombonato‐Prado1
1Bone Research Lab, Department of Basic and Oral Biology, School of Dentistry, USP - Universidade de Sao Paulo, Ribeirao Preto, SP, Brazil
2Department of Oral and Maxillofacial Surgery and Periodontology, School of Dentistry, USP - Universidade de Sao Paulo, Ribeirao Preto, SP, Brazil

Tóm tắt

Abstract Recent studies suggest that osteoporosis, in addition to the damage caused in long bones, may cause deterioration in the jaws, especially in alveolar bone sites, with effects in the progress of periodontal disease as well as in bone healing. The aim of this study was to evaluate the effect of osteoporosis in the metabolism of rat alveolar bone osteoblasts. There were used 10 female rats divided in two experimental groups (Sham and OVX), which were ovariectomized and after 8 weeks euthanized to collect mandibular bone samples in order to isolate osteoblastic cells. The cells were cultured in 24-well plates to perform the in vitro experiments. After 7, 10 and 14 days, there were evaluated cell proliferation by MTT assay, in situ detection of alkaline phosphatase (ALP) as well as mineralized nodules and expression of genes associated to bone remodeling. Results showed that at 7, 10 and 14 days cell proliferation was lower for OVX group. In situ detection of ALP was higher at 7 days and lower at 10 and 14 days in OVX group. At 17 and 21 days, OVX group had a significative decrease of mineralization nodules. There was a downregulation in the expression of Alp, Bglap and Runx2 genes and an upregulation of Opg in OVX group, whereas Opn and Rankl modulation was similar between the evaluated groups. Our results suggest that osteoporosis has a deleterious effect on alveolar bone cells from ovariectomized rats, which might affect the treatment of diseases associated to the jaw bones.

Từ khóa


Tài liệu tham khảo

Anbinder AL, 2016, Periodontal disease exacerbates systemic ovariectomy-induced bone loss in mice, Bone, 83, 241, 10.1016/j.bone.2015.11.014

Kolte RA, 2017, Risk assessment of osteoporosis in pre- and postmen-opausal periodontal healthy and chronic periodontitis women with digital panoramic radiographs, J Indian Soc Perodontol, 2, 461, 10.4103/jisp.jisp_238_17

de Franca NA, 2016, Dietary pat-terns and bone mineral density in Brazilian postmenopausal women with osteoporosis: a cross-sectional study, Eur J Clin Nutr, 70, 85, 10.1038/ejcn.2015.27

Akesson K, 2013, Capture the Fracture: a Best Practice Framework and global campaign to break the fragility frac-ture cycle, Osteoporos Int, 24, 2135, 10.1007/s00198-013-2348-z

Shen CL, 2015, Green tea supplementation bene-fits body composition and improves bone properties in obese female rats fed with high-fat diet and caloric restricted diet, Nutr Res, 35, 1095, 10.1016/j.nutres.2015.09.014

Mashalkar VN, 2018, A cross-sectional study to assess and correlate osteoporosis and periodontitis among postmenopausal women: a dual energy x-ray absorptiometry study, J Midlife Health, 9, 2

Wang CJ, 2016, Osteoporosis and periodontitis, Curr Osteoporos Rep, 14, 284, 10.1007/s11914-016-0330-3

Ayed MS, 2019, Evaluating the possible association between sustemic osteoporosis and periodontal disease pro-gression in potmenopausal women, Dis Mon, 65, 193, 10.1016/j.disamonth.2018.11.001

Arioka M, 2019, Osteoporotic Changes in the Periodontium Impair Alveolar Bone Healing, J Dent Res, 98, 450, 10.1177/0022034518818456

Scalize PH, 2016, Poly(Vinylidene Fluoride-Trifluorethylene)/barium titanate membrane promotes de novo bone formation and may modulate gene expression in osteoporotic rat model, J Mater Sci Mater Med, 27, 180, 10.1007/s10856-016-5799-x

Gregory CA, 2004, An Alizarin red-based assay of miner-alization by adherent cells in culture: comparison with cetylpyridinium chloride extrac-tion, Anal Biochem, 329, 77, 10.1016/j.ab.2004.02.002

Thorndike EA, 1998, In search of an animal model for postmenopausal diseases, Front Biosci, 3, c17, 10.2741/A260

Lee C, 2019, Site-specific and time-course changes of postmenopausal osteoporosis in rat mandible: comparative study with fe-mur, Sci Rep, 9, 14155, 10.1038/s41598-019-50554-w

Oliveira GR, 2019, Lycopene influences osteoblast functional activity and prevents femur bone loss in female rats submitted to an experimental model of osteoporosis, J Bone Miner Metab, 37, 658, 10.1007/s00774-018-0970-8

Semeghini MS, 2018, Menopause transition promotes distinct modulation of mRNAs and miRNAs ex-pression in calvaria and bone marrow osteoblastic cells, Cell Biol Int, 42, 12, 10.1002/cbin.10802

Aubin JE, 1998, Advances in the osteoblast lineage, Biochem Cell Biol, 76, 899, 10.1139/o99-005

Yu SJ, 2012, Proliferation and differentiation of os-teoblasts from the mandible of osteoporotic rats, Exp Biol Med, 237, 395, 10.1258/ebm.2011.011217

He YX, 2011, Impaired bone healing pattern in mice with ovariectomy- induced osteoporosis: a drill-hole defect model, Bone, 48, 1388, 10.1016/j.bone.2011.03.720

Chen CH, 2018, An osteo-penic/osteoporotic phenotype delays alveolar bone repair, Bone, 112, 212, 10.1016/j.bone.2018.04.019

Jin P, 2015, Role of (-)-epigallocatechin-3-gallate in the osteogenic differentiation of human bone marrow mesenchymal stem cells: An en-hancer or an inducer?, Exp Ther Med, 10, 828, 10.3892/etm.2015.2579

Jiang LB, 2018, Bone marrow stem cells-derived exosomes extracted from osteoporosis patients inhibit osteogenesis via microRNA-21/SMAD7, Eur Rev Med Pharmacol Sci, 22, 6221

Cheng F, 2019, MiRNA-365a-3p promotes the progression of osteopo-rosis by inhibiting osteogenic differentiation via targeting Runx2, Eur Rev Med Phar-macol Sci, 23, 7766

Zheng ZG, 2017, Anhydroicaritin, a SREBPs inhibitor, inhibits Rankl-induced osteoclastic differentiation and improves di-abetic osteoporosis in STZ-induced mice, Eur J Pharmacol, 809, 156, 10.1016/j.ejphar.2017.05.017